Leadership
  • Bonnie H. Anderson
    Chairman of the Board and Chief Executive Officer
    Bonnie H. Anderson
    Chairman of the Board and Chief Executive Officer
    Her career spans over 30 years in regulated diagnostics and life science markets. Ms. Anderson cofounded Veracyte in 2008 and served as the company’s President and Chief Executive Officer until 2016, when she was also appointed Chairman of the Board.
    MORE ABOUT Bonnie >
  • Keith Kennedy
    Chief Operating Officer and Chief Financial Officer
    Keith Kennedy
    Chief Operating Officer and Chief Financial Officer
    Mr. Kennedy was named chief operating officer and chief financial officer of Veracyte in July 2019. He has served as the company’s chief financial officer since December 2016 and secretary since November 2017.
    MORE ABOUT Keith >
  • Giulia C. Kennedy, Ph.D.
    Chief Scientific and Medical Officer
    Giulia C. Kennedy, Ph.D.
    Chief Scientific and Medical Officer
    Dr. Kennedy’s scientific leadership, Veracyte continually pushes the boundaries of what is possible in genomic diagnostics, using big data and machine learning to develop tests that answer critical clinical questions.
    MORE ABOUT Giulia >
  • John W. Hanna
    Chief Commercial Officer
    John W. Hanna
    Chief Commercial Officer
    John has held senior management positions including Vice President of Marketing and Vice President of Endocrinology. During his tenure, Mr. Hanna has helped define clear patient-centric value propositions for Veracyte’s genomic tests, leading to their broad physician adoption and payer reimbursement.
    MORE ABOUT John >
  • Ashish Kheterpal
    Chief Information Officer
    Ashish Kheterpal
    Chief Information Officer
    Mr. Kheterpal has led Veracyte’s technology development and deployment in support of the company’s infrastructure, operations and product development as it has grown to a three-product company with over $65 million in annual revenue.
    MORE ABOUT Ashish >
  • Alfred “Freddie” Bowie, Jr., Ph.D.
    Vice President, Corporate and Business Development
    Alfred “Freddie” Bowie, Jr., Ph.D.
    Vice President, Corporate and Business Development
    In his role of Vice President of Corporate and Business Development, Dr. Bowie will lead the company’s strategic planning process and is responsible for managing biopharmaceutical collaborations; identifying, evaluating and executing technology and business partnerships; and managing licensing and acquisitions.
    MORE ABOUT Alfred “Freddie” >